AtonRa Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,985
| Closed | -$1.01M | – | 120 |
|
|
2021
Q4 | $1.01M | Buy |
11,985
+1,182
| +11% | +$99.4K | 0.35% | 93 |
|
|
2021
Q3 | $974K | Buy |
10,803
+638
| +6% | +$57.5K | 0.33% | 98 |
|
|
2021
Q2 | $969K | Sell |
10,165
-10,852
| -52% | -$1.03M | 0.36% | 97 |
|
|
2021
Q1 | $2.39M | Buy |
21,017
+3,371
| +19% | +$384K | 1.07% | 41 |
|
|
2020
Q4 | $2.44M | Buy |
+17,646
| New | +$2.44M | 1.2% | 34 |
|